aluates Reports

$ 0.0

Automative

Global Neoantigen Peptides Manufacturing Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-36K13740

Global Neoantigen Peptides Manufacturing Market Research Report 2023

BUY CHAPTERS

Global Neoantigen Peptides Manufacturing Market Research Report 2025

Code: QYRE-Auto-36K13740

Report

May 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CPC Scientific Inc.

PolyPeptide Group

Genscript Biotech

Kaneka Eurogentec SA

Vivitide

ALMAC

BCN Peptides

Creative Peptides

Pepscan

Provepharm

Gyros Protein Technologies

AnaSpec

Creosalus

Neoantigen Peptides Manufacturing Market

The global market for Neoantigen Peptides Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Neoantigen Peptides Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Neoantigen Peptides Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Neoantigen Peptides Manufacturing in Pharmaceutical/Vaccine Developer Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Neoantigen Peptides Manufacturing include Cpc Scientific Inc, Polypeptide Group, Genscript Biotech, Kaneka Eurogentec SA, Vivitide, Almac, Bcn Peptides, Creative Peptides, Pepscan, Provepharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Neoantigen Peptides Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neoantigen Peptides Manufacturing.

The Neoantigen Peptides Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neoantigen Peptides Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neoantigen Peptides Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neoantigen Peptides Manufacturing Market Report

Report Metric	Details
Report Name	Neoantigen Peptides Manufacturing Market
Segment by Type	Olid Phase Synthesis Solution Phase Synthesis
Segment by Application	Pharmaceutical/Vaccine Developer Companies Contract Research Organizations (CRO) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cpc Scientific Inc, Polypeptide Group, Genscript Biotech, Kaneka Eurogentec SA, Vivitide, Almac, Bcn Peptides, Creative Peptides, Pepscan, Provepharm, Creosalus, Gyros Protein Technologies, Anaspec
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neoantigen Peptides Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neoantigen Peptides Manufacturing Market report?

Ans: The main players in the Neoantigen Peptides Manufacturing Market are Cpc Scientific Inc, Polypeptide Group, Genscript Biotech, Kaneka Eurogentec SA, Vivitide, Almac, Bcn Peptides, Creative Peptides, Pepscan, Provepharm, Creosalus, Gyros Protein Technologies, Anaspec

What are the Application segmentation covered in the Neoantigen Peptides Manufacturing Market report?

Ans: The Applications covered in the Neoantigen Peptides Manufacturing Market report are Pharmaceutical/Vaccine Developer Companies, Contract Research Organizations (CRO), Others

What are the Type segmentation covered in the Neoantigen Peptides Manufacturing Market report?

Ans: The Types covered in the Neoantigen Peptides Manufacturing Market report are Olid Phase Synthesis, Solution Phase Synthesis

Recommended Reports

Peptide Manufacturing

Cancer Therapeutics

Diagnostics & Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neoantigen Peptides Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Olid Phase Synthesis

1.2.3 Solution Phase Synthesis

1.3 Market by Application

1.3.1 Global Neoantigen Peptides Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical/Vaccine Developer Companies

1.3.3 Contract Research Organizations (CRO)

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neoantigen Peptides Manufacturing Market Perspective (2020-2031)

2.2 Global Neoantigen Peptides Manufacturing Growth Trends by Region

2.2.1 Global Neoantigen Peptides Manufacturing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Neoantigen Peptides Manufacturing Historic Market Size by Region (2020-2025)

2.2.3 Neoantigen Peptides Manufacturing Forecasted Market Size by Region (2026-2031)

2.3 Neoantigen Peptides Manufacturing Market Dynamics

2.3.1 Neoantigen Peptides Manufacturing Industry Trends

2.3.2 Neoantigen Peptides Manufacturing Market Drivers

2.3.3 Neoantigen Peptides Manufacturing Market Challenges

2.3.4 Neoantigen Peptides Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neoantigen Peptides Manufacturing Players by Revenue

3.1.1 Global Top Neoantigen Peptides Manufacturing Players by Revenue (2020-2025)

3.1.2 Global Neoantigen Peptides Manufacturing Revenue Market Share by Players (2020-2025)

3.2 Global Neoantigen Peptides Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neoantigen Peptides Manufacturing Revenue

3.4 Global Neoantigen Peptides Manufacturing Market Concentration Ratio

3.4.1 Global Neoantigen Peptides Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Peptides Manufacturing Revenue in 2024

3.5 Global Key Players of Neoantigen Peptides Manufacturing Head office and Area Served

3.6 Global Key Players of Neoantigen Peptides Manufacturing, Product and Application

3.7 Global Key Players of Neoantigen Peptides Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neoantigen Peptides Manufacturing Breakdown Data by Type

4.1 Global Neoantigen Peptides Manufacturing Historic Market Size by Type (2020-2025)

4.2 Global Neoantigen Peptides Manufacturing Forecasted Market Size by Type (2026-2031)

5 Neoantigen Peptides Manufacturing Breakdown Data by Application

5.1 Global Neoantigen Peptides Manufacturing Historic Market Size by Application (2020-2025)

5.2 Global Neoantigen Peptides Manufacturing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Neoantigen Peptides Manufacturing Market Size (2020-2031)

6.2 North America Neoantigen Peptides Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Neoantigen Peptides Manufacturing Market Size by Country (2020-2025)

6.4 North America Neoantigen Peptides Manufacturing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neoantigen Peptides Manufacturing Market Size (2020-2031)

7.2 Europe Neoantigen Peptides Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Neoantigen Peptides Manufacturing Market Size by Country (2020-2025)

7.4 Europe Neoantigen Peptides Manufacturing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neoantigen Peptides Manufacturing Market Size (2020-2031)

8.2 Asia-Pacific Neoantigen Peptides Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Neoantigen Peptides Manufacturing Market Size by Region (2020-2025)

8.4 Asia-Pacific Neoantigen Peptides Manufacturing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neoantigen Peptides Manufacturing Market Size (2020-2031)

9.2 Latin America Neoantigen Peptides Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Neoantigen Peptides Manufacturing Market Size by Country (2020-2025)

9.4 Latin America Neoantigen Peptides Manufacturing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neoantigen Peptides Manufacturing Market Size (2020-2031)

10.2 Middle East & Africa Neoantigen Peptides Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Neoantigen Peptides Manufacturing Market Size by Country (2020-2025)

10.4 Middle East & Africa Neoantigen Peptides Manufacturing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cpc Scientific Inc

11.1.1 Cpc Scientific Inc Company Details

11.1.2 Cpc Scientific Inc Business Overview

11.1.3 Cpc Scientific Inc Neoantigen Peptides Manufacturing Introduction

11.1.4 Cpc Scientific Inc Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.1.5 Cpc Scientific Inc Recent Development

11.2 Polypeptide Group

11.2.1 Polypeptide Group Company Details

11.2.2 Polypeptide Group Business Overview

11.2.3 Polypeptide Group Neoantigen Peptides Manufacturing Introduction

11.2.4 Polypeptide Group Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.2.5 Polypeptide Group Recent Development

11.3 Genscript Biotech

11.3.1 Genscript Biotech Company Details

11.3.2 Genscript Biotech Business Overview

11.3.3 Genscript Biotech Neoantigen Peptides Manufacturing Introduction

11.3.4 Genscript Biotech Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.3.5 Genscript Biotech Recent Development

11.4 Kaneka Eurogentec SA

11.4.1 Kaneka Eurogentec SA Company Details

11.4.2 Kaneka Eurogentec SA Business Overview

11.4.3 Kaneka Eurogentec SA Neoantigen Peptides Manufacturing Introduction

11.4.4 Kaneka Eurogentec SA Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.4.5 Kaneka Eurogentec SA Recent Development

11.5 Vivitide

11.5.1 Vivitide Company Details

11.5.2 Vivitide Business Overview

11.5.3 Vivitide Neoantigen Peptides Manufacturing Introduction

11.5.4 Vivitide Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.5.5 Vivitide Recent Development

11.6 Almac

11.6.1 Almac Company Details

11.6.2 Almac Business Overview

11.6.3 Almac Neoantigen Peptides Manufacturing Introduction

11.6.4 Almac Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.6.5 Almac Recent Development

11.7 Bcn Peptides

11.7.1 Bcn Peptides Company Details

11.7.2 Bcn Peptides Business Overview

11.7.3 Bcn Peptides Neoantigen Peptides Manufacturing Introduction

11.7.4 Bcn Peptides Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.7.5 Bcn Peptides Recent Development

11.8 Creative Peptides

11.8.1 Creative Peptides Company Details

11.8.2 Creative Peptides Business Overview

11.8.3 Creative Peptides Neoantigen Peptides Manufacturing Introduction

11.8.4 Creative Peptides Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.8.5 Creative Peptides Recent Development

11.9 Pepscan

11.9.1 Pepscan Company Details

11.9.2 Pepscan Business Overview

11.9.3 Pepscan Neoantigen Peptides Manufacturing Introduction

11.9.4 Pepscan Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.9.5 Pepscan Recent Development

11.10 Provepharm

11.10.1 Provepharm Company Details

11.10.2 Provepharm Business Overview

11.10.3 Provepharm Neoantigen Peptides Manufacturing Introduction

11.10.4 Provepharm Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.10.5 Provepharm Recent Development

11.11 Creosalus

11.11.1 Creosalus Company Details

11.11.2 Creosalus Business Overview

11.11.3 Creosalus Neoantigen Peptides Manufacturing Introduction

11.11.4 Creosalus Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.11.5 Creosalus Recent Development

11.12 Gyros Protein Technologies

11.12.1 Gyros Protein Technologies Company Details

11.12.2 Gyros Protein Technologies Business Overview

11.12.3 Gyros Protein Technologies Neoantigen Peptides Manufacturing Introduction

11.12.4 Gyros Protein Technologies Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.12.5 Gyros Protein Technologies Recent Development

11.13 Anaspec

11.13.1 Anaspec Company Details

11.13.2 Anaspec Business Overview

11.13.3 Anaspec Neoantigen Peptides Manufacturing Introduction

11.13.4 Anaspec Revenue in Neoantigen Peptides Manufacturing Business (2020-2025)

11.13.5 Anaspec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CPC Scientific Inc.

PolyPeptide Group

Genscript Biotech

Kaneka Eurogentec SA

Vivitide

ALMAC

BCN Peptides

Creative Peptides

Pepscan

Provepharm

Gyros Protein Technologies

AnaSpec

Creosalus

List of Tables

Table 1. Global Neoantigen Peptides Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Olid Phase Synthesis

Table 3. Key Players of Solution Phase Synthesis

Table 4. Global Neoantigen Peptides Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Neoantigen Peptides Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Neoantigen Peptides Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Neoantigen Peptides Manufacturing Market Share by Region (2020-2025)

Table 8. Global Neoantigen Peptides Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Neoantigen Peptides Manufacturing Market Share by Region (2026-2031)

Table 10. Neoantigen Peptides Manufacturing Market Trends

Table 11. Neoantigen Peptides Manufacturing Market Drivers

Table 12. Neoantigen Peptides Manufacturing Market Challenges

Table 13. Neoantigen Peptides Manufacturing Market Restraints

Table 14. Global Neoantigen Peptides Manufacturing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Neoantigen Peptides Manufacturing Market Share by Players (2020-2025)

Table 16. Global Top Neoantigen Peptides Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Peptides Manufacturing as of 2024)

Table 17. Ranking of Global Top Neoantigen Peptides Manufacturing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Neoantigen Peptides Manufacturing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Neoantigen Peptides Manufacturing, Headquarters and Area Served

Table 20. Global Key Players of Neoantigen Peptides Manufacturing, Product and Application

Table 21. Global Key Players of Neoantigen Peptides Manufacturing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Neoantigen Peptides Manufacturing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Neoantigen Peptides Manufacturing Revenue Market Share by Type (2020-2025)

Table 25. Global Neoantigen Peptides Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Neoantigen Peptides Manufacturing Revenue Market Share by Type (2026-2031)

Table 27. Global Neoantigen Peptides Manufacturing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Neoantigen Peptides Manufacturing Revenue Market Share by Application (2020-2025)

Table 29. Global Neoantigen Peptides Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Neoantigen Peptides Manufacturing Revenue Market Share by Application (2026-2031)

Table 31. North America Neoantigen Peptides Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Neoantigen Peptides Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Neoantigen Peptides Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Neoantigen Peptides Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Neoantigen Peptides Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Neoantigen Peptides Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Neoantigen Peptides Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Neoantigen Peptides Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Neoantigen Peptides Manufacturing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Neoantigen Peptides Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Neoantigen Peptides Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Neoantigen Peptides Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Neoantigen Peptides Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Neoantigen Peptides Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Neoantigen Peptides Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Cpc Scientific Inc Company Details

Table 47. Cpc Scientific Inc Business Overview

Table 48. Cpc Scientific Inc Neoantigen Peptides Manufacturing Product

Table 49. Cpc Scientific Inc Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 50. Cpc Scientific Inc Recent Development

Table 51. Polypeptide Group Company Details

Table 52. Polypeptide Group Business Overview

Table 53. Polypeptide Group Neoantigen Peptides Manufacturing Product

Table 54. Polypeptide Group Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 55. Polypeptide Group Recent Development

Table 56. Genscript Biotech Company Details

Table 57. Genscript Biotech Business Overview

Table 58. Genscript Biotech Neoantigen Peptides Manufacturing Product

Table 59. Genscript Biotech Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 60. Genscript Biotech Recent Development

Table 61. Kaneka Eurogentec SA Company Details

Table 62. Kaneka Eurogentec SA Business Overview

Table 63. Kaneka Eurogentec SA Neoantigen Peptides Manufacturing Product

Table 64. Kaneka Eurogentec SA Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 65. Kaneka Eurogentec SA Recent Development

Table 66. Vivitide Company Details

Table 67. Vivitide Business Overview

Table 68. Vivitide Neoantigen Peptides Manufacturing Product

Table 69. Vivitide Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 70. Vivitide Recent Development

Table 71. Almac Company Details

Table 72. Almac Business Overview

Table 73. Almac Neoantigen Peptides Manufacturing Product

Table 74. Almac Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 75. Almac Recent Development

Table 76. Bcn Peptides Company Details

Table 77. Bcn Peptides Business Overview

Table 78. Bcn Peptides Neoantigen Peptides Manufacturing Product

Table 79. Bcn Peptides Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 80. Bcn Peptides Recent Development

Table 81. Creative Peptides Company Details

Table 82. Creative Peptides Business Overview

Table 83. Creative Peptides Neoantigen Peptides Manufacturing Product

Table 84. Creative Peptides Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 85. Creative Peptides Recent Development

Table 86. Pepscan Company Details

Table 87. Pepscan Business Overview

Table 88. Pepscan Neoantigen Peptides Manufacturing Product

Table 89. Pepscan Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 90. Pepscan Recent Development

Table 91. Provepharm Company Details

Table 92. Provepharm Business Overview

Table 93. Provepharm Neoantigen Peptides Manufacturing Product

Table 94. Provepharm Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 95. Provepharm Recent Development

Table 96. Creosalus Company Details

Table 97. Creosalus Business Overview

Table 98. Creosalus Neoantigen Peptides Manufacturing Product

Table 99. Creosalus Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 100. Creosalus Recent Development

Table 101. Gyros Protein Technologies Company Details

Table 102. Gyros Protein Technologies Business Overview

Table 103. Gyros Protein Technologies Neoantigen Peptides Manufacturing Product

Table 104. Gyros Protein Technologies Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 105. Gyros Protein Technologies Recent Development

Table 106. Anaspec Company Details

Table 107. Anaspec Business Overview

Table 108. Anaspec Neoantigen Peptides Manufacturing Product

Table 109. Anaspec Revenue in Neoantigen Peptides Manufacturing Business (2020-2025) & (US$ Million)

Table 110. Anaspec Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Neoantigen Peptides Manufacturing Picture

Figure 2. Global Neoantigen Peptides Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neoantigen Peptides Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. Olid Phase Synthesis Features

Figure 5. Solution Phase Synthesis Features

Figure 6. Global Neoantigen Peptides Manufacturing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Neoantigen Peptides Manufacturing Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical/Vaccine Developer Companies Case Studies

Figure 9. Contract Research Organizations (CRO) Case Studies

Figure 10. Others Case Studies

Figure 11. Neoantigen Peptides Manufacturing Report Years Considered

Figure 12. Global Neoantigen Peptides Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Neoantigen Peptides Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Neoantigen Peptides Manufacturing Market Share by Region: 2024 VS 2031

Figure 15. Global Neoantigen Peptides Manufacturing Market Share by Players in 2024

Figure 16. Global Top Neoantigen Peptides Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Peptides Manufacturing as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Neoantigen Peptides Manufacturing Revenue in 2024

Figure 18. North America Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Neoantigen Peptides Manufacturing Market Share by Country (2020-2031)

Figure 20. United States Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Neoantigen Peptides Manufacturing Market Share by Country (2020-2031)

Figure 24. Germany Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Neoantigen Peptides Manufacturing Market Share by Region (2020-2031)

Figure 32. China Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Neoantigen Peptides Manufacturing Market Share by Country (2020-2031)

Figure 40. Mexico Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Neoantigen Peptides Manufacturing Market Share by Country (2020-2031)

Figure 44. Turkey Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Neoantigen Peptides Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Cpc Scientific Inc Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 48. Polypeptide Group Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 49. Genscript Biotech Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 50. Kaneka Eurogentec SA Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 51. Vivitide Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 52. Almac Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 53. Bcn Peptides Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 54. Creative Peptides Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 55. Pepscan Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 56. Provepharm Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 57. Creosalus Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 58. Gyros Protein Technologies Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 59. Anaspec Revenue Growth Rate in Neoantigen Peptides Manufacturing Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cosmetic Peptide Manufacturing Market Research Report 2024

Global GMP Grade Peptide Market Research Report 2024

Global Ovalbumin Peptide Market Research Report 2024

Global Peptide Analysis Market Research Report 2025

Global High Pure Peptides Market Research Report 2025

Global Peptide Antibiotics Market Research Report 2025

Global Oat Peptides Market Research Report 2024

Global Beta amyloid Peptide Market Research Report 2025

Global Peptide API Market Research Report 2024

Global Silk Peptide Market Research Report 2024

Global Standard Peptide Custom Synthesis Service Market Research Report 2024

Global MHC peptide Complexes Market Research Report 2024

Global Peptide Synthesis Reactor Market Research Report 2024

Global Peptide Purification System Market Research Report 2024

Global Oral Peptide Therapeutics Market Research Report 2024

Global Peptide Analyzing Tools Market Research Report 2025

Global Peptide Modification Service Market Research Report 2024

Global Peptide Analyzing Tool Market Research Report 2025

Catalog Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions